시장보고서
상품코드
1863870

FISH 프로브 시장 : 유형별, 제품 카테고리별, 프로브 형식별, 기술별, 용도별, 최종사용자별, 지역별

Fluorescent in Situ Hybridization Probe Market, By Type, By Product Category, By Probe Format, By Technology, By Application, By End User, By Geography

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

FISH 프로브 시장은 2025년에 13억 4,000만 달러로 추정되고, 2032년까지 22억 8,000만 달러에 이를 것으로 예측되며, 2025-2032년 CAGR 7.9%로 성장할 전망입니다.

분석 범위 분석 상세
기준 연도 2024년 시장 규모(2025년) 13억 4,000만 달러
실적 데이터 2020-2024년 예측 기간 2025-2032년
예측 기간(2025-2032년) CAGR 7.90% 예측 금액(2032년) 22억 8,000만 달러

세계 형광 in situ hybridization(FISH) 프로브 시장은 분자진단 산업에서 중요한 부문으로 유전자 분석 및 염색체 이상 검출에 필수적인 도구로 작용하고 있습니다. 형광 in situ 하이브리드화 프로브는 세포 내 상보적인 핵산 서열에 결합하는 형광 표지된 DNA 또는 RNA 서열을 이용하여 형광 현미경으로 특정 유전적 표적을 정확하게 시각화 및 국소화할 수 있습니다. 이 기술은 정확하고 신속하며 비용 효율적인 유전자 분석 기능을 제공함으로써 세포유전학, 종양 진단, 산전 선별검사 및 연구에 혁명을 일으켰습니다.

시장에는 유전자좌 특이적 식별 프로브, 센트로미아 카운팅 프로브, 전염색체 페인팅 프로브, 브레이크아파르트 프로브 등 특정 진단 용도에 맞게 설계된 다양한 프로브 유형이 있습니다. 유전성 질환의 유병률 증가, 개인 맞춤형 의료에 대한 수요 증가, 분자생물학 기술의 발전, 그리고 전 세계 임상 실험실에서 FISH 기술의 채택이 확대되면서 시장 성장을 주도하고 있습니다. 자동화의 통합, 다중화 기능의 개발, 프로브의 민감도 및 특이성 향상은 FISH 프로브의 임상적 유용성을 지속적으로 향상시키고 있으며, 이 시장을 현대의 유전자 진단 및 치료 정책 결정 과정의 기반 기술로 자리매김하고 있습니다.

시장 역학

세계 형광 in situ 하이브리드화 프로브 시장은 주로 몇 가지 강력한 요인에 의해 견인되어 견고한 성장 궤도를 유지하고 있습니다. 전 세계적으로 증가하는 유전성 질환, 암, 염색체 이상 발생률은 고급 진단 도구를 필요로 하고 있으며, FISH 프로브는 임상 진단 및 조사 응용 분야에서 필수적인 요소로 자리매김하고 있습니다. 노화에 따른 유전성 질환에 취약한 고령 인구 증가, 조기 질병 발견에 대한 인식 증가, 산전 및 착상 전 유전자 검사의 적용 범위 확대로 인해 시장 수요가 크게 증가하고 있습니다. 고감도, 고특이성 프로브 개발, 자동화 통합, 다중화 기능, 고성능 이미징 시스템 등의 기술 발전으로 의료시설의 도입률이 지속적으로 증가하고 있습니다.

그러나 FISH 장비 및 인프라에 대한 높은 초기 투자 비용, 복잡한 규제 승인 절차, FISH 분석을 수행하고 해석할 수 있는 숙련된 인력 부족, 차세대 시퀀싱 및 마이크로어레이 분석과 같은 대체 분자진단 기술과의 경쟁 등 시장에는 뚜렷한 제약도 존재합니다. 잠재적인 교차 혼성화 문제, 시간이 많이 걸리는 프로토콜, 전문적인 실험 시설 요건과 같은 기술적 제약도 시장 확대에 걸림돌로 작용하고 있습니다. 그러나 액체 생검의 적용 확대, 표적 치료를 위한 동반 진단, 의료 인프라가 개선되고 있는 신흥 시장, 포인트 오브 케어 FISH 시스템 개발, 유전체 연구에 대한 연구 자금 증가 등을 통해 큰 기회가 창출되고 있습니다.

본 보고서의 주요 특징

  • 세계의 형광 in situ 하이브리드화 프로브 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 CAGR을 조사하여 전해드립니다.
  • 또한, 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
  • 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
  • 이 보고서는 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 형광 in situ 하이브리드화 프로브 시장의 주요 기업 프로파일을 제공합니다.
  • 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
  • "세계 형광 in situ 하이브리드화 프로브 시장" 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자들은 세계 형광 in situ 하이브리드화 프로브 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 분석 목적과 전제조건

  • 분석 목적
  • 전제조건
  • 약어

제2장 시장 전망

  • 보고서 설명
    • 시장 정의와 범위
  • 주요 요약

제3장 시장 역학, 규제 및 동향 분석

  • 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 영향 분석
  • 주요 발전
  • 규제 시나리오
  • 제품 발매 및 승인
  • PEST 분석
  • Porter의 Five Forces 분석
  • 인수합병(M&A) 시나리오
  • 업계 동향

제4장 세계의 FISH 프로브 시장 : 유형별(2020-2032년)

  • 서론
  • DNA 프로브
  • RNA 프로브

제5장 세계의 FISH 프로브 시장 : 제품 카테고리별(2020-2032년)

  • 서론
  • 장비 및 시스템
  • 소모품(프로브, 시약, 키트)
  • 소프트웨어 및 서비스

제6장 세계의 FISH 프로브 시장 : 프로브 형식별(2020-2032년)

  • 서론
  • Locus-specific probes
  • Centromeric/Alphoid/Repeat probes
  • Whole chromosome (painting) probes
  • Multiplex/combinatorial probes

제7장 세계의 FISH 프로브 시장 : 기술별(2020-2032년)

  • 서론
  • Q-FISH(정량 FISH)
  • 플로우 피쉬
  • 단색 FISH
  • 멀티플렉스 FISH(mFISH/스펙트럼 FISH)
  • 기타 하이브리드 기술

제8장 세계의 FISH 프로브 시장 : 용도별(2020-2032년)

  • 서론
  • 암 진단 및 모니터링
  • 유전성 질환 감지 및 세포 유전학
  • 산전 및 산후 스크리닝
  • 감염증 및 병원체 감지
  • 연구(유전자 발현 및 세포생물학)
  • 기타

제9장 세계의 FISH 프로브 시장 : 최종사용자별(2020-2032년)

  • 서론
  • 임상 진단실험실 및 병원
  • 학술연구기관
  • 제약 및 바이오테크놀러지 기업
  • 계약연구기관(CRO)
  • 유전학 전문 연구소 및 참조 연구소

제10장 세계의 FISH 프로브 시장 : 지역별(2020-2032년)

  • 서론
  • 북미
      • 미국
      • 캐나다
  • 라틴아메리카
      • 브라질
      • 아르헨티나
      • 멕시코
      • 기타 라틴아메리카
  • 유럽
      • 독일
      • 영국
      • 스페인
      • 프랑스
      • 이탈리아
      • 러시아
      • 기타 유럽
  • 아시아태평양
      • 중국
      • 인도
      • 일본
      • 호주
      • 한국
      • ASEAN
      • 기타 아시아태평양
  • 중동
      • GCC 국가
      • 이스라엘
      • 기타 중동
  • 아프리카
      • 남아프리카
      • 북아프리카
      • 중앙아프리카

제11장 경쟁 구도

  • Thermo Fisher Scientific
  • PerkinElmer
  • Agilent Technologies
  • Hoffmann-La Roche(Roche)
  • Merck KGaA
  • Oxford Gene Technology(OGT)
  • Biosearch Technologies(LGC)
  • Abnova Corporation
  • Biocare Medical LLC
  • Creative Biolabs
  • Genemed Biotechnologies
  • Horizon Diagnostics
  • BioDot
  • GSP Research institute
  • QIAGEN

제12장 애널리스트의 제안

  • ' Wheel of Fortune '
  • 애널리스트의 견해
  • Coherent Opportunity Map(COM)

제13장 참고 문헌이 및 분석 방법

  • 참고 문헌
  • 분석 방법
  • Coherent Market Insights에 대해
LSH

Fluorescent in Situ Hybridization Probe Market is estimated to be valued at USD 1.34 Bn in 2025 and is expected to reach USD 2.28 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1.34 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.90% 2032 Value Projection: USD 2.28 Bn

The global fluorescent in situ hybridization probe market represents a critical segment within the molecular diagnostics industry, serving as an essential tool for genetic analysis and chromosomal abnormality detection. fluorescent in situ hybridization probes utilize fluorescently labeled DNA or RNA sequences that bind to complementary nucleic acid sequences within cells, enabling precise visualization and localization of specific genetic targets under fluorescence microscopy. This technology has revolutionized cytogenetics, oncology diagnostics, prenatal screening, and research applications by providing highly accurate, rapid, and cost-effective genetic analysis capabilities.

The market encompasses various probe types including locus-specific identifier probes, centromeric enumeration probes, whole chromosome painting probes, and break-apart probes, each designed for specific diagnostic applications. Growing prevalence of genetic disorders, increasing demand for personalized medicine, advancement in molecular biology techniques, and rising adoption of FISH technology in clinical laboratories worldwide are driving significant market expansion. The integration of automation, development of multiplexing capabilities, and enhancement of probe sensitivity and specificity continue to enhance the clinical utility of FISH probes, positioning this market as a cornerstone technology in modern genetic diagnostics and therapeutic decision-making processes.

Market Dynamics

The global fluorescent in situ hybridization probe market is primarily driven by several compelling factors that collectively fuel its robust growth trajectory. The increasing incidence of genetic disorders, cancer, and chromosomal abnormalities worldwide necessitates advanced diagnostic tools, positioning FISH probes as indispensable components in clinical diagnostics and research applications. Rising geriatric population susceptible to age-related genetic conditions, growing awareness about early disease detection, and expanding applications in prenatal and preimplantation genetic screening significantly boost market demand. Technological advancements including development of more sensitive and specific probes, automation integration, multiplexing capabilities, and enhanced imaging systems continue to drive adoption rates across healthcare facilities.

However, the market faces notable restraints including high initial investment costs for FISH equipment and infrastructure, complex regulatory approval processes, limited skilled workforce capable of performing and interpreting FISH analyses, and competition from alternative molecular diagnostic technologies such as next-generation sequencing and microarray analysis. Technical limitations including potential cross-hybridization issues, time-consuming protocols, and requirements for specialized laboratory facilities also pose challenges to market expansion. Nevertheless, significant opportunities emerge through expanding applications in liquid biopsy, companion diagnostics for targeted therapies, emerging markets with improving healthcare infrastructure, development of point-of-care FISH systems, and increasing research funding for genomics studies.

Key Features of the Study

  • This report provides in-depth analysis of the global fluorescent in situ hybridization probe market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global fluorescent in situ hybridization probe market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific, PerkinElmer, Agilent Technologies, F. Hoffmann-La Roche (Roche), Merck KGaA, Oxford Gene Technology (OGT), Biosearch Technologies (LGC), Abnova Corporation, Biocare Medical LLC, Creative Biolabs, Genemed Biotechnologies, Horizon Diagnostics, BioDot, GSP Research Institute, and QIAGEN
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global fluorescent in situ hybridization probe market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fluorescent in situ hybridization probe market

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • DNA probes
    • RNA probes
  • Product Category Insights (Revenue, USD Bn, 2020 - 2032)
    • Instruments and Systems
    • Consumables (probes, reagents, kits)
    • Software and Services
  • Probe Format Insights (Revenue, USD Bn, 2020 - 2032)
    • Locus-specific probes
    • Centromeric/Alphoid/Repeat probes
    • Whole chromosome (painting) probes
    • Multiplex/combinatorial probes
  • Technology Insights (Revenue, USD Bn, 2020 - 2032)
    • Q-FISH (quantitative FISH)
    • Flow-FISH
    • Single-color FISH
    • Multiplex FISH (mFISH/spectral FISH)
    • Other hybrid techniques
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Cancer diagnostics and monitoring
    • Genetic disorder detection and cytogenetics
    • Prenatal and postnatal screening
    • Infectious disease and pathogen detection
    • Research (gene expression and cell biology)
    • Others
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Clinical diagnostic laboratories and hospitals
    • Academic and research institutions
    • Pharmaceutical and biotechnology companies
    • Contract Research Organizations (CROs)
    • Reference and specialized genetics laboratories
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Thermo Fisher Scientific
    • PerkinElmer
    • Agilent Technologies
    • Hoffmann-La Roche (Roche)
    • Merck KGaA
    • Oxford Gene Technology (OGT)
    • Biosearch Technologies (LGC)
    • Abnova Corporation
    • Biocare Medical LLC
    • Creative Biolabs
    • Genemed Biotechnologies
    • Horizon Diagnostics
    • BioDot
    • GSP Research Institute
    • QIAGEN

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Fluorescent in Situ Hybridization Probe Market, By Type
    • Global Fluorescent in Situ Hybridization Probe Market, By Product Category
    • Global Fluorescent in Situ Hybridization Probe Market, By Probe Format
    • Global Fluorescent in Situ Hybridization Probe Market, By Technology
    • Global Fluorescent in Situ Hybridization Probe Market, By Application
    • Global Fluorescent in Situ Hybridization Probe Market, By End User
    • Global Fluorescent in Situ Hybridization Probe Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • industry Trends

4. Global Fluorescent in Situ Hybridization Probe Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • DNA probes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • RNA probes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Fluorescent in Situ Hybridization Probe Market, By Product Category, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Instruments and Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Consumables (probes, reagents, kits)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Software and Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Fluorescent in Situ Hybridization Probe Market, By Probe Format, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Locus-specific probes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Centromeric/Alphoid/Repeat probes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Whole chromosome (painting) probes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Multiplex/combinatorial probes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Fluorescent in Situ Hybridization Probe Market, By Technology, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Q-FISH (quantitative FISH)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Flow-FISH
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Single-color FISH
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Multiplex FISH (mFISH/spectral FISH)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other hybrid techniques
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Fluorescent in Situ Hybridization Probe Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cancer diagnostics and monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Genetic disorder detection and cytogenetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Prenatal and postnatal screening
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Infectious disease and pathogen detection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research (gene expression and cell biology)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Fluorescent in Situ Hybridization Probe Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Clinical diagnostic laboratories and hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Academic and research institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pharmaceutical and biotechnology companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Reference and specialized genetics laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Fluorescent in Situ Hybridization Probe Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Probe Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Probe Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Probe Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Probe Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • india
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Probe Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn) Market
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Probe Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hoffmann-La Roche (Roche)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Oxford Gene Technology (OGT)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biosearch Technologies (LGC)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abnova Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biocare Medical LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Creative Biolabs
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Genemed Biotechnologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Horizon Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioDot
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GSP Research institute
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제